Aimei Health Technology (NASDAQ:AFJK) Announces Earnings Results

Aimei Health Technology (NASDAQ:AFJK) announced its quarterly earnings data on Thursday. The company reported ($0.03) earnings per share (EPS) for the quarter, FiscalAI reports.

Aimei Health Technology Stock Performance

Shares of NASDAQ AFJK traded up $0.30 during midday trading on Thursday, hitting $12.30. 336 shares of the company traded hands, compared to its average volume of 22,046. Aimei Health Technology has a 12-month low of $6.75 and a 12-month high of $130.37. The firm has a market cap of $38.99 million, a P/E ratio of 76.88 and a beta of 0.90. The stock has a 50-day moving average price of $21.90 and a 200 day moving average price of $33.25.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Jane Street Group LLC bought a new position in Aimei Health Technology in the fourth quarter worth approximately $302,000. Geode Capital Management LLC bought a new stake in Aimei Health Technology during the 4th quarter valued at $413,000. Quarry LP lifted its holdings in shares of Aimei Health Technology by 6.4% in the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock worth $1,891,000 after buying an additional 10,000 shares during the period. Finally, Clear Street Group Inc. lifted its holdings in shares of Aimei Health Technology by 36.5% in the 4th quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock worth $5,334,000 after buying an additional 22,294 shares during the period. Institutional investors own 45.58% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a report on Wednesday, June 24th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.